reference/26904181

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26904181

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial
endingPage	211
issn	0278-5846
issueIdentifier	1
pageRange	208-211
publicationName	Progress in Neuro-Psychopharmacology and Biological Psychiatry
startingPage	208
bibliographicCitation	Cho SJ, Yook K, Kim B, Choi TK, Lee KS, Kim YW, Lee JE, Suh S, Yook KH, Lee S. Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011 Jan;35(1):208–11. doi: 10.1016/j.pnpbp.2010.11.006.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_700fb79db2a0bb1b84be62481a2507fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e6c4e48c836ad078d9b3698c85dead7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10ef88c0d241b99315a18b18e3224d54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06a3b6c154411f1f8c6808e5e3bfe13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11305ae8fc0d29ebef8fc08bc7f1abef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d43c92d91b9864c9bb7f3609c314928a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0278ba8baac886a360360cfdeeeaa39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64284ba20099a851aae224b8171bf650 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_429809e06f73409788509ad1c41d403c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ac9fbdeeff826a9e9e0668b17ba3682
date	2011-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21095214 https://doi.org/10.1016/j.pnpbp.2010.11.006
isPartOf	https://portal.issn.org/resource/ISSN/0278-5846 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6714 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6752
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0028338 http://id.nlm.nih.gov/mesh/M0001387 http://id.nlm.nih.gov/mesh/M0013724 http://id.nlm.nih.gov/mesh/M0021770 http://id.nlm.nih.gov/mesh/M0107850
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014150Q000627 http://id.nlm.nih.gov/mesh/D003072Q000188 http://id.nlm.nih.gov/mesh/D008803Q000031 http://id.nlm.nih.gov/mesh/D018967Q000627 http://id.nlm.nih.gov/mesh/D012559Q000188 http://id.nlm.nih.gov/mesh/D000929Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008803Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000078785 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003072Q000209 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012559Q000150 http://id.nlm.nih.gov/mesh/D011569 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10410 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129357553 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897

Total number of triples: 60.